Enovis (ENOV) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
6 Apr, 2026Executive summary
The annual meeting is scheduled for May 19, 2026, via live webcast, with record date March 30, 2026.
Stockholders can vote online, by phone, mail, or during the virtual meeting.
Proxy materials are primarily distributed electronically to reduce costs and environmental impact.
Voting matters and shareholder proposals
Four proposals: election of ten directors, advisory approval of executive compensation (say-on-pay), ratification of Ernst & Young LLP as auditor, and approval of an amendment to the 2020 Omnibus Incentive Plan.
Board recommends voting FOR all proposals.
Shareholders may submit proposals and director nominations for future meetings, subject to deadlines and requirements.
Board of directors and corporate governance
Board consists of ten nominees with diverse backgrounds, 80% independent, 40% women, and 30% racially/ethnically diverse.
Board committees: Audit, Nominating and Corporate Governance, and Compensation and Human Capital Management (CHCM).
Strong governance practices: independent chair, majority voting, mandatory retirement age of 75, anti-hedging/pledging, and clawback policies.
Annual board and committee self-assessments and ongoing director education.
Latest events from Enovis
- Virtual annual meeting to vote on directors, auditor, compensation, and incentive plan.ENOV
Proxy filing6 Apr 2026 - Double-digit growth, tech innovation, and ASC expansion fuel strong outlook for 2026.ENOV
2026 CG Musculoskeletal Conference4 Mar 2026 - 2025 saw robust sales growth, margin gains, and innovation, with 2026 guidance targeting further improvements.ENOV
Q4 202526 Feb 2026 - Lima integration and new product launches drive growth, margin expansion, and innovation in 2025.ENOV
CG 2025 Musculoskeletal Conference13 Feb 2026 - Q2 sales up 23%, margin expansion, and Lima integration ahead of plan with raised EPS guidance.ENOV
Q2 20242 Feb 2026 - Integration and portfolio expansion drive growth, margin gains, and strong outlook into 2025.ENOV
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Lima acquisition and innovation drive 2024 growth, margin gains, and integration progress.ENOV
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - 2024 growth guided at 5%-6% with margin expansion as integration headwinds ease.ENOV
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Q3 sales up 21% and adjusted EPS up 30%, led by Reconstructive and Lima integration.ENOV
Q3 202416 Jan 2026